Impressive list of Institutional-Holders,yet PPS=stagnant,IS there hope after all? IMO after the last June disappointment on top of all the management scandals they're running out of time to really hit one out of the park, a triple home run like the Dodgers just had e.g.:
They need something that actually cures or at least significantly impedes growth/spread of cancer and/or other deadly disease:
Is that too much to ask of a company that's devoted billions and lost blllions of investor money in that very cause?
Galena Biopharma Inc, Inst Holders, 3Q 2017 (GALE)
1 day 15 hours 47 minutes ago - DJNF
The following table shows the largest shareholders in GALENA BIOPHARMA INC COM (GALE) for the quarter ended September 30, 2017, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 09/30/2017
Institution Shares Shares % Last
Held Changed Held Report
Sabby Capital LLC 2,644,522 178,662 6.886 06/30
Renaissance Technologies LLC 2,221,086 620,811 5.783 06/30
KCG Americas LLC 224,050 195,230 0.583 06/30
Element Capital Management LLC 160,238 160,238 0.417 06/30
Goldman Sachs & Co. LLC (Priva 131,604 (82,477) 0.343 06/30
BlackRock Fund Advisors 131,434 (481,678) 0.342 06/30
Ergoteles LLC 120,800 120,800 0.315 06/30
SSgA Funds Management Inc. 114,431 (145,494) 0.298 06/30
Millennium Management LLC 111,996 (196,910) 0.292 06/30
Crescent Grove Advisors LLC 100,000 100,000 0.260 06/30
Citadel Advisors LLC 93,273 (69,304) 0.243 06/30
Morgan Stanley & Co. LLC 67,529 7,407 0.176 06/30
LMR Partners LLP 58,023 58,023 0.151 06/30
Geode Capital Management LLC 51,783 (50,915) 0.135 06/30
DAFNA Capital Management LLC 46,145 0 0.120 06/30
Northern Trust Investments In 39,908 (88,862) 0.104 06/30
Tower Research Capital LLC 35,078 (20,871) 0.091 06/30
D. E. Shaw & Co. LP 23,733 23,733 0.062 06/30
The California Public Employee 23,582 0 0.061 06/30
Squarepoint OPS LLC 20,942 20,942 0.055 06/30
Susquehanna Financial Group LL 19,946 (1,552) 0.052 06/30
Wells Fargo Advisors Financial 19,682 0 0.051 06/30
Mariner Wealth Advisors LLC 15,150 15,150 0.039 03/31
Morgan Stanley Smith Barney LL 13,739 0 0.036 06/30
David Vaughan Investments Inc 13,002 0 0.034 06/30
Guggenheim Funds Investment Ad 12,776 0 0.033 06/30
The Bank of New York Mellon Co 8,590 (17,451) 0.022 06/30
Citigroup Global Markets Inc. 7,041 1,941 0.018 06/30
BNY Mellon Capital Markets LLC 5,459 (6,289) 0.014 06/30
Spot Trading LLC 5,000 0 0.013 06/30
Vanguard Fiduciary Trust Co. 4,690 (54,778) 0.012 06/30
Winfield Associates Inc. 3,000 0 0.008 06/30
Meeder Asset Management Inc. 1,989 508 0.005 06/30
BlackRock Advisors LLC 1,385 (3,917) 0.004 06/30
Simplex Trading LLC 1,000 1,000 0.003 06/30
Royal Alliance Associates Inc 747 (3) 0.002 06/30
Triad Hybrid Solutions LLC 740 0 0.002 06/30
Wells Fargo Clearing Services 700 0 0.002 06/30
Pittenger & Anderson Inc. 400 400 0.001 06/30
Securities America Advisors I 387 (250) 0.001 06/30
UBS Securities LLC 351 (22,095) 0.001 06/30
Springbok Capital Management L 300 (7,500) 0.001 06/30
Manulife Asset Management Ltd. 248 (26) 0.001 06/30
Valley National Advisers Inc. 128 0 0.000 06/30
IFP Advisors Inc. 112 0 0.000 06/30
San Francisco Sentry Investmen 100 100 0.000 06/30
RBC Dominion Securities Inc. 91 90 0.000 06/30
Deutsche Asset Management Inve 84 (88,645) 0.000 06/30
CWM LLC 25 0 0.000 09/30
NEXT Financial Group Inc. 25 25 0.000 06/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2017. All Rights Reserved.
(END) Dow Jones Newswires
They have until March 2018 to come up with a miracle without having to do another confidence-destroying R/S, and they'd better stay away from their infamous Public Offerings Below Current Stock Price:
these investors are a show of confidence, they don't buy to short:
On September 21, 2017, The Nasdaq Stock Market ("Nasdaq") notified Galena Biopharma, Inc. (the "Company") that, while the Company had not regained compliance with the minimum bid price requirement, it was eligible for an additional 180-day grace period, or until March 19, 2018, to regain compliance with the $1.00 per share minimum bid price requirement.
October 20, 2017 03:03 ET (07:03 GMT)
AI
